don’t disagree with anything you said. But I think you missed my points.
Didn’t say OTC is bad…it’s just not enough. Maybe Invictus needs a successful flow test (or two) first, but if it is to appreciably increase its sp, it needs to expand beyond ASX…AND the OTC. Simply no volume there. Apple is no longer an OTC stock, is it?
And yes, of course Recon is down from highs. But that has zero to do with it DID go to high levels. Based on nothing. Yet IVZ has not, despite two discoveries. Why?
don’t disagree with anything you said. But I think you missed my...
-
- There are more pages in this discussion • 4,336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
